Aandeel EQL Pharma AB | Filter Basic-Info
Aandeel: EQL Pharma AB (Zweden smallcaps)
| Koers | 49.65 | Hoogste koers | 49.65 |
| Laagste koers | 49.65 | 1-jrs rend. | -38.70 |
| Sector | Consumentendiensten | Subsector | Supermarkten |
Loading...
Contactinformatie:Land: Zweden
Sectorvergelijking EQL Pharma AB
Loading...
| Jaar | Omzet | Totaal omzet sector | Marktaandeel |
|---|---|---|---|
| 2019 | 7 | 1,402,857 | 0.00 % |
| 2020 | 18 | 1,380,983 | 0.00 % |
| 2021 | 39 | 1,523,029 | 0.00 % |
| 2022 | 23 | 1,773,749 | 0.00 % |
| 2023 | 23 | 1,808,889 | 0.00 % |
Adviezen EQL Pharma AB
No Records Found
Nieuws EQL Pharma AB
No Records Found
Rapporten EQL Pharma AB
No Records Found
Profiel EQL Pharma AB
No Records Found
Resultaten EQL Pharma AB
| Resultaten |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Omzet |
|
|
|
|
|
| Kosten |
|
|
|
|
|
| Nettowinst |
|
|
|
|
|
| Winstmarge |
|
|
|
|
|
| ROI |
|
|
|
|
|
Balans EQL Pharma AB
| Balans |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Eigen vermogen |
|
|
|
|
|
| Vreemd vermogen |
|
|
|
|
|
| Totaal vermogen |
|
|
|
|
|
| Solvabiliteit |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Kasstroom |
|
|
|
|
|
| Werknemers |
|
|
|
|
|
| Omzet per werknemer |
|
|
|
|
|
| Kasstroom / vreemd vermogen |
|
|
|
|
|
Details EQL Pharma AB
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Koers |
8.58
|
10.59
|
10.75
|
12.90
|
39.70
|
| Winst per aandeel |
0.0
|
0.0
|
0.0
|
0.01
|
0.03
|
| Koers / winst-verhouding |
0.0
|
0.0
|
0.0
|
1290.00
|
1655.00
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Boekwaarde |
0.0
|
0.22
|
0.26
|
0.26
|
0.31
|
| Boek / koers |
0.0
|
0.02
|
0.02
|
0.02
|
0.01
|
| Kasstroom per aandeel |
0.0
|
0.0
|
0.02
|
0.02
|
0.20
|
| Aandelen |
0
|
25
|
29
|
29
|
29
|
| Marktkap. |
0,00
|
263,81
|
312,43
|
374,92
|
1.443,01
|
Dividend EQL Pharma AB
Koersinfo EQL Pharma AB
|
Datum
|
Koers
|
|---|---|
|
21 dec
|
49.65
|
| Over ons | Netwerk | Partners | Social |
| Over AnalistMethodeDisclaimerAdverterenPersContactRSS feedinfo@analist.nl | Analist.nlLinksISINGlossary |
vwd GroupEuronextPrudena.comAAII.comNASDAQBATS Chi-x
|
 
|
©2025 Analist. Alle rechten voorbehouden
Developed and maintained by 